Recent Updates
Recently added Catalysts
UFPT Positive Sentiment

UFP Technologies Announces Record Q2 Results

Monday, August 3, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: UFP Technologies, Inc. reported impressive financial results for Q2 2026, achieving a net income of $20.9 million, which represents a 21.4% increase from the previous year. The company's net sales also rose by 15.1%, reaching $174.0 million. These results highlight the company's strong performance in the medical device and packaging sectors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Record net income of $20.9 million for Q2 2026.
  • Net income increased by 21.4% compared to Q2 2025.
  • Net sales reached $174.0 million, a significant growth.

Full Press Release Details

NEWBURYPORT, Mass.--(BUSINESS WIRE)--UFP Technologies, Inc. (Nasdaq: UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.9 million for its second quarter ended June 30, 2026, 21.4% higher than net income of $17.2 million for the second quarter of 2025. Net sales for the quarter ended June 30, 2026 were $174.0 million, 15.1%

Frequently Asked Questions

What was UFP Technologies' net income for Q2 2026?

UFP Technologies reported a net income of $20.9 million for Q2 2026.

How much did net income increase compared to Q2 2025?

Net income increased by 21.4% compared to Q2 2025.

What were the net sales for UFP Technologies in Q2 2026?

Net sales for Q2 2026 were $174.0 million.

What sectors does UFP Technologies specialize in?

UFP Technologies specializes in medical devices and sterile packaging.

ShareAdd on Google
Tags: UFPT Viatris Investor Conferences Healthcare UFP Technologies Q2 results net income medical devices
Last updated: Aug 3, 2026

Biotech snapshot

Cash runway
$20M liquidity · $0M/mo burn
Low dilution risk